An invention titled “Novel Arylidene Barbiturate Derivatives That Can Be Used as Drug Candidates in Cancer Treatment,” co-invented by Prof. Dr. Zuhal Gerçek, an academic at the Department of Chemistry, Faculty of Science at Zonguldak Bülent Ecevit University (BEUN), has been deemed eligible for patent registration by the European Patent Office.

The invention, titled “Novel Arylidene Barbiturate Derivatives That Can Be Used as Drug Candidates in Cancer Treatment,” was developed by Prof. Dr. Zuhal Gerçek, a faculty member at BEUN’s Department of Chemistry, Faculty of Science; Prof. Dr. Mustafa Güzel, a faculty member at the Faculty of Pharmacy at Istanbul Medipol University; and Betül Yaşin, who is pursuing her doctoral studies in the Department of Medical Pharmacology. The invention has been deemed eligible for patent registration by the European Patent Office.

The invention covers four different chemical compounds and various chemical forms of these compounds for the development of drugs that may be used in cancer treatment. The study focuses on evaluating these molecules for the development of new drug candidates.

The invention was also registered by the Turkish Patent and Trademark Office (TÜRKPATENT) on July 22, 2024.

Rector Ulusoy: “We Are Pleased to See Our Scientific Research Included in International Patent Processes”

In his remarks on the topic, BEUN Rector Prof. Dr. Ahmet Ulusoy stated:

“The fact that scientific studies conducted at our universities are included in national and international patent processes is important for protecting research outputs under intellectual property rights. We are pleased with the progress made in the European patent process for this study, among whose co-inventors is our faculty member Prof. Dr. Zuhal Gerçek. I hope that this collaboration with Istanbul Medipol University will contribute to the advancement of scientific research and strengthen knowledge sharing across different disciplines. I congratulate the faculty members and our researcher who contributed to this study and wish them continued success.”